IFP Advisors, Inc - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2021$12,000
+50.0%
1,463
+58.5%
0.00%
Q1 2021$8,000
+14.3%
923
+16.1%
0.00%
Q4 2020$7,000
-41.7%
795
-39.8%
0.00%
-100.0%
Q3 2020$12,0001,3200.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$00
-100.0%
0.00%
Q2 2018$020.0%0.00%
Q1 2018$020.0%0.00%
Q4 2017$020.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders